Opus Genetics, Inc. (NASDAQ:IRD) Receives Consensus Rating of “Moderate Buy” from Analysts

Opus Genetics, Inc. (NASDAQ:IRD) Receives Consensus Rating of “Moderate Buy” from Analysts

Opus Genetics, Inc. (NASDAQ:IRD – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the ten research firms that are currently covering the firm, MarketBeat reports. One investment analyst has rated the stock with a sell rating, eight have assigned a buy rating and one has given a strong buy rating to the company. The average 12-month price target among brokerages that have issued ratings on the stock in the last yea…